#EyeOintments sold nationwide recalled due to infection risk

Story by Kate Gibson
February 26, 2024

"Multiple brands of lubricant eye ointments are being recalled due to a risk of infection after federal inspectors found unsterile conditions at the Indian plant where the products were manufactured.

"The recall by Brassica Pharma Pvt. in Thane, a city in the Indian state of Maharashtra, comes after a deadly outbreak last year of #EyeInfections linked to artificial tears made by another Indian firm.

"Sold nationwide by retailers including #CVS Health and #Walmart, the latest recall involves four products by brands #Equate, #CVSHealth and #AACEPharmaceuticals, according to the notice posted Monday by the U.S. Food and Drug Administration.

"All have expiration dates starting April 2024 and running through September 2025. The recalled products include:

- Equate Lubricant Eye Ointment in a 3.5-gram tube, packaged in box with UPC code: 681131395298.
- Equate Style Lubricant Eye Ointment in a 3.5-gram tube in box with UPC code: 681131395304.
- CVS Health Lubricant Eye Ointment in a 3.5-gram tube in box with UPC code: 050428634141.
- #LubricantPM Ointment in a 3.5 gram tube, sold in box with UPC code: 371406124356.

"People should stop using the recalled eye ointments and can return them to the place of purchase. Those with questions can call 1-833-225-9564 or [email protected].

"#EzriCare artificial tears were among the brands recalled last year by #DelsamPharma of #ChennaiIndia, as health officials identified 81 people in 18 states as suffering from infections, with four #deaths and multiple cases of #VisionLoss reported.

"In January, the #FDA warned against copycat #EyeDrops because of the risk of infection."

https://www.msn.com/en-us/health/other/eye-ointments-sold-nationwide-recalled-due-to-infection-risk/ar-BB1iVEtg

MSN

FDA faults company behind recalled eye drops for multiple violations, bans imports

Global Pharma's eye drops have been linked to a U.S. outbreak which has led to at least five people losing their vision.

CBS News